SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-19-003262
Filing Date
2019-04-25
Accepted
2019-04-25 07:02:19
Documents
4
Period of Report
2019-06-06
Effectiveness Date
2019-04-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A def14a.htm DEF 14A 716738
2 GRAPHIC def14ag001.jpg GRAPHIC 4750
3 GRAPHIC def14ag002.jpg GRAPHIC 78989
4 GRAPHIC def14ag003.jpg GRAPHIC 64260
  Complete submission text file 0001558370-19-003262.txt   921951
Mailing Address 640 LEE ROAD SUITE 200 WAYNE PA 19087
Business Address 640 LEE ROAD SUITE 200 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

IRS No.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37581 | Film No.: 19765318
SIC: 2834 Pharmaceutical Preparations